FR2826580B1 - Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices - Google Patents

Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices

Info

Publication number
FR2826580B1
FR2826580B1 FR0108679A FR0108679A FR2826580B1 FR 2826580 B1 FR2826580 B1 FR 2826580B1 FR 0108679 A FR0108679 A FR 0108679A FR 0108679 A FR0108679 A FR 0108679A FR 2826580 B1 FR2826580 B1 FR 2826580B1
Authority
FR
France
Prior art keywords
kpv
epidermic
scars
wounds
renewal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0108679A
Other languages
English (en)
Other versions
FR2826580A1 (fr
Inventor
Yann Mahe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0108679A priority Critical patent/FR2826580B1/fr
Priority to PCT/FR2002/002270 priority patent/WO2003002087A1/fr
Publication of FR2826580A1 publication Critical patent/FR2826580A1/fr
Application granted granted Critical
Publication of FR2826580B1 publication Critical patent/FR2826580B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
FR0108679A 2001-06-29 2001-06-29 Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices Expired - Fee Related FR2826580B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0108679A FR2826580B1 (fr) 2001-06-29 2001-06-29 Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices
PCT/FR2002/002270 WO2003002087A1 (fr) 2001-06-29 2002-06-28 Utilisation du tripeptide lys-pro-val (kpv) en cosmetique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108679A FR2826580B1 (fr) 2001-06-29 2001-06-29 Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices

Publications (2)

Publication Number Publication Date
FR2826580A1 FR2826580A1 (fr) 2003-01-03
FR2826580B1 true FR2826580B1 (fr) 2005-09-30

Family

ID=8864973

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0108679A Expired - Fee Related FR2826580B1 (fr) 2001-06-29 2001-06-29 Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices

Country Status (2)

Country Link
FR (1) FR2826580B1 (fr)
WO (1) WO2003002087A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2857581B1 (fr) * 2003-07-18 2007-11-30 Inst Europ Biolog Cellulaire Association utile dans le traitement preventif et curatif de l'alopecie d'un agent anti-inflammatoire et d'un filtre uvb
EP2222325A2 (fr) * 2007-11-19 2010-09-01 Universitätsklinikum Münster Compositions pour la réduction du stress oxydatif et leurs utilisations
US7887992B2 (en) * 2008-12-23 2011-02-15 E. I. Du Pont De Nemours And Company Photosensitive paste and process for production of pattern using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
CA1323839C (fr) * 1987-05-11 1993-11-02 Loren Ralph Pickart Methodes pour stimuler la pousse des poils
FR2733421B1 (fr) * 1995-04-28 1997-06-06 Oreal Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2738746B1 (fr) * 1995-09-19 1997-11-14 Oreal Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament
SE9801571D0 (sv) * 1998-05-05 1998-05-05 Wapharm Ab Melanokortin-1-receptorselektiva föreningar
WO2000004873A1 (fr) * 1998-07-22 2000-02-03 Smith & Nephew Plc Compositions dermatologiques pour le traitement de cicatrices
EP1092427B1 (fr) * 1999-10-04 2007-05-23 L'oreal Utilisation d'une peptide prévenant les réactions d'intolérance de la peau, notamment dans des compositions cosmétiques

Also Published As

Publication number Publication date
FR2826580A1 (fr) 2003-01-03
WO2003002087A1 (fr) 2003-01-09

Similar Documents

Publication Publication Date Title
HUP0300588A3 (en) Production of recombinant blood clotting factors in human cell lines
DE60203463D1 (de) Vorichtung zur Bestimmung von physikalischen Informationen bezüglich Einschränkungen des täglichen Lebens in Beziehung
ATE456375T1 (de) Verwendung von botulinum toxin zur behandlung von neuralgischen schmerzen
ATE326524T1 (de) Verwendung von lactobacillus zur verminderung des fibrinogengehalts im blut
ATE319437T1 (de) Verwendungen von ppar-gamma-agonisten in neutrophil-verursachten erkrankungen
HUP0301991A2 (hu) IL-18-inhibitorok alkalmazása atheroszklerózis kezelésére és/vagy megelżzésére
ATE410195T1 (de) Hydrokolloidzusammensetzungen
FR2812197B1 (fr) Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2841470B1 (fr) Utilisation d'isoflavones pour la preparation de compositions topiques utiles pour favoriser l'amincissement et methode de traitement cosmetique associee
ATE232378T1 (de) Reinigungspflaster zur verbesserung des hautzustandes
DE60229235D1 (de) D kupfersulfaten und sucralphat
FR2826580B1 (fr) Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices
ATE256461T1 (de) Benutzung von comt-inhibitoren als analgetika
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
DE602005007862D1 (de) Hautflegemittel die salicylsäure enthalten
FR2841781B1 (fr) Utilisation de peptides pour favoriser la regeneration cutannee
EE200200337A (et) Uued ühendid ning nende kasutamine
ES2184971T3 (es) Utilizacion de polidimetilsiloxanos de grupos glucosidos como agentes hidratantes en una composicion cosmetica o dermatologica.
MA27406A1 (fr) Utilisation du sel distrontique de l'acide 2-[n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
AU2003287915A8 (en) Use of factor vii polypeptides for preventing formation of inhibitors to blood coagulation factor viii and ix
GB2382990B (en) Improvements in and relating to adhesive dressings
WO2002004521A3 (fr) Proteines a activite du type integrine
FR2848827B1 (fr) Utilisation de dialkylsulfones dans des compositions cosmetiques de soin des ongles pour favoriser la pousse de l'ongle
PL358841A1 (en) Production of recombinant blood clotting factors in human cell lines
FR2872037B1 (fr) Nouvelle utilisation cosmetique ou dermatologique de l'acide pyroglutamique

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090228